ArticleThe Lancet. Respiratory medicine2020
Antihypertensive drugs and risk of COVID-19?
Article in The Lancet. Respiratory medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review.The American journal of emergency medicine · 2021Pooled it
- Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.Diabetes & metabolic syndromePooled it
- Updates on Palliative Medicine in the COVID-19 Era.Journal of clinical medicine · 2022Article
- Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?Advances in biological regulation · 2021Review
- Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation.Future virology · 2021Article
- Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-Analysis.Infection & chemotherapy · 2021Review
- A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021Article
- Analgesic Drugs and COVID-19.Journal of clinical medicine · 2021Article
- Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic.Research in social & administrative pharmacy : RSAP · 2021Article
- The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19.International journal of cardiology. Heart & vasculature · 2020Article
- ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror.Inflammopharmacology · 2020Article
- Collider bias undermines our understanding of COVID-19 disease risk and severity.Nature communications · 2020Article
- Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19.Cellular signalling · 2020Review
- Cardiometabolic Health: Key in Reducing Adverse COVID-19 Outcomes.Global heart · 2020Article
- Factors Influencing Global Variations in COVID-19 Cases and Fatalities; A Review.Healthcare (Basel, Switzerland) · 2020Article
- Review
- What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.Clinical transplantation · 2020Review
- COVID-19: Present and Future Challenges for Dental Practice.International journal of environmental research and public health · 2020Review
- Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium.Frontiers in neurology · 2020Article
- Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.Frontiers in endocrinology · 2020Review
Corrections and comments
- Commented on by
- Commented on by
- Comment on
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.